Safety and Efficacy of Lu-177 PSMA-617 Versus Established Therapies in mCRPC: Pooled Evidence from Randomized Phase II/III Trials Other Scholarly Work

Ganiyani, MA, Sheraz, A, Syed, DH et al. (2026). Safety and Efficacy of Lu-177 PSMA-617 Versus Established Therapies in mCRPC: Pooled Evidence from Randomized Phase II/III Trials . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 125(1), e1-e1.

cited authors

  • Ganiyani, MA; Sheraz, A; Syed, DH; Avudaiappan, A Pon; Nagendran, A; Abdalla, A; Pustake, M; Valagni, G; Kaiser, A; Manoharan, M; Mehta, MP; Garje, R

authors

publication date

  • May 1, 2026

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • CA, Palm Desert

publisher

  • ELSEVIER SCIENCE INC

start page

  • e1

end page

  • e1

volume

  • 125

issue

  • 1